Fusion Pharmaceuticals Inc. Additional Paid in Capital
Fusion Pharmaceuticals Inc. had Additional Paid in Capital of $1.30 million as of 2020-01-31, per its 10-K filed 2022-03-17.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent › Additional Paid in Capital
us-gaap:AdditionalPaidInCapital · last filed 2022-03-17
- 2020-01-31: Additional Paid in Capital $1.30M.
| Period end | Additional Paid in Capital |
|---|---|
| 2020-01-31 | $1.30M 10-K · filed 2022-03-17 |